Therapeutic binding molecules
US11795225B2 · kind B2 · utility
0Cited by
0References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2021 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Sep 10, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to binding molecules (e.g. antibodies) for the treatment of cancer, and related antibody-drug conjugates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.